一种专原药可注射配方用于协同癌症免疫疗法
Yang Li1, Yuting Lu1, Xiaoling Zhu2
1Department of Pharmacy, Center for Regenerative and Aging Medicine, The Fourth Affiliated Hospital of School of Medicine and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu 322000, China.
Journal of colloid and interface science
|February 10, 2025
概括
一种新型的专原药注射配方 (PIF) 通过向瘤提供特别的STINGagonist MSA-2和IDO抑制剂NLG919来增强癌症免疫疗法. 这种有针对性的方法改善了药物输送,减少了副作用,促进了抗瘤免疫反应.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药物运输 药物运输 药物运输
背景情况:
- 免疫疗法已经彻底改变了癌症治疗,但面临着诸如低响应率和免疫相关不良事件等挑战.
- 开发提高免疫疗法的疗效和安全性的策略对于临床进步至关重要.
研究的目的:
- 开发一种专原药注射配方 (PIF) 用于增强癌症免疫疗法.
- 创建一种针对瘤的药物输送系统,以改善药物动力学特性并减少非标毒性.
主要方法:
- 通过用IDO抑制剂NLG919.2对STING激动剂MSA-2进行化,合成了一种前药MSA-NLG.
- 将前制成一个基于白蛋白的纳米粒子 (MSA-NLG@BSA) 用于注射.
- 评估了配方的药理动力学特性,瘤向性,透性和抗瘤免疫反应在体外和体内.
主要成果:
- MSA-NLG@BSA配方延长了循环时间,增强了瘤聚合和透,并在正常组织中保持不活跃.
- 前药在瘤细胞内分离为活性MSA-2和NLG919,刺激强大的抗瘤免疫反应.
- MSA-2促进了细胞毒性细胞因子的分泌,重塑了免疫细胞群体,而NLG919抵消了IDO介导的免疫抑制.
结论:
- 使用MSA-NLG@BSA (PIF) 响应瘤环境的前药物策略显示出提高癌症免疫治疗疗效的巨大潜力.
- 这种新的配方提供了一种有希望的方法来减少与免疫相关的不良事件,并改善免疫疗法的临床转化.
更多相关视频
相关概念视频
Tumor Immunotherapy
464
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
464
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Combined Effects of Drugs: Synergism
3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.7K
Cancer Vaccines
329
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
329


